Диссертация (1139673), страница 42
Текст из файла (страница 42)
1— 155,180.Keown P.A. Predicting long-term outcome in renal transplantation / P.A.Keown // Kidney Int. — 2013. — Vol.84, №4. — P.650-652.181.Keyzer D.K. Human cytomegalovirus and kidney transplantation: Aclinician’s update / D. K. Keyzer, V.S. Laecke, P. Peeters, R. Vanholder // Am J KidneyDis. 2011. 58: 118— 126.182.Kim E. Treatment issues surrounding hepatitis C in renal transplantation: Areview / E. Kim, H.H. Ko, E.M. Yoshida // Ann Hepatol. — 2011. — Vol. 10. — P. 5 —14.183.Knight R.J. The influence of acute rejection on long-term allograft survival:a comparison of living and cadaveric donor transplantation / R.J.
Knight, L. Burrows, C.Bodian // Transplantation. — 2001. — Vol.72, №1. — P. 69-76.184.Known O.J. The impact of gender and age matching for long-term graftsurvival in living donor renal transplantation / O.J. Known, J.Y. Kwak, C.M. Kang//Transplant. Proceedings. — 2005. — Vol. 37, №2. — P. 726-728.185.Ko K.S. Infections after renal transplantation / K.S. Ko, D.O.
Cho, J.H. Ahn,T. Leeet al. // Transplant. Proceedings. — 1994. — Vol. 26. — P. 2072-2074.301186.Koo D.D.H. Cadaver versus living donor kidneys: Impact of donor factorson antigen induction before transplantation / D.D.H. Koo, K.I. Welsh, A.J. Mclaren, J.A.Roake // Kidney Int. — 1999. — Vol.56. — P. 1551-1559.187.Koyama H. Rejection episodes / H. Koyama, J.M. Cecka // Clin.
Transpl. —Los Angeles: UCLA Tissue Typing Laboratory, 1993. — P. 391-394.188.Kyllönen L. Renal transplant recipients with graft survival longer than 20years: report on 107 cases / L. Kyllönen, S. Koskimies, K. Salmela // Transpl. Proceed.— 2001. — Vol.33, №4. — P. 2444-2445.189.LaiX. Recipient-Related Risk Factors for Graft Failure and Death in ElderlyKidney TransplantRecipients / X. Lai, G.
Chen,J. Qiu, C. Wanget al.// PLoS One.— 2014.— Vol.12, №9(11) . — e112938.190.Lamb K.E. Long-term renal allograft survival in the United States: a criticalreappraisal / K.E. Lamb, S. Lodhi, H.U. Meier-Kriesche // Am. J. Transpl. — 2011. —Vol.11, №3. — P. 450-462.191.Leavey S.F. Cross-sectional and longitudinal predictors of serum albumin inhemodialysis patients / S.F. Leavey, R.L. Strawderman, E.W. Young, R. Saran et al.//Kidney International. — 2000. — P. 58. — P.
2119-2128.192.Lenihan C.R.A New Clinical Prediction Tool for 5-Year Kidney TransplantOutcome / C.R. Lenihan, J.B. Lockridge,J.C. Tan // Am. J. Kidney Dis. — 2014. — Vol.63, №4. — P. 549-551.193.Leung K.C. Psychosocial aspect in renal patient / K.C. Leung // PeritonealDialysis Internat. — 2003. — Vol. 23, № 2.
— P. 90-94.194.Levitsky J. AST Infectious Diseases Community of Practice: Viral hepatitisin solid organ transplant recipients / J. Levitsky, K. Doucette // Am J Transplant. — 2009.— №4. — P. 116— 130.195.Levy G.A. C2 monitoring for optimising cyclosporin immunosuppressionfrom the Neoral formulation /G.A.
Levy // BioDrugs. — 2001. — Vol.15. — P.279-290.196.Lim W.H. Outcomes of kidney transplantation from older living donors /W.H. Lim, P. Clayton, G. Wong, S.B. Campbell et al. // Transplantation. — 2013. —Vol.95, №1. — P. 106-113.302197.LocseyL. The importance of obesity and hyperlipidemia in patients withrenal transplants / L. Locsey, L.Asztalos, Z.S. Kincses et al. // Int. Urol.
Nephrol. — 1998.— Vol.30. — P. 767-775.198.London G.M. Alterations of left ventricular hypertrophy in and survival ofpatients receiving hemodialysis: follow-up of an interventional study /G.M. London,B.Pannier, A.P. Guerin, J. Blacher et al.// J. Am. Soc. Nephrol.— 2001. — Vol.12, №12.— P. 2759-2767.199.Lowrie E.G. Death risk in hemodialysis patients: The predictive value ofcommonly measured variables and an evaluation of death rate differences betweenfacilities / E.G. Lowrie, N.L. Lew // Am. J.
Kidney Dis. — 1990. — Vol.15. — P. 458482.200.Lozano R. Global and reginal mortality from 235 causes of death for 20 agegroups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study2010 / R. Lozano, M. Naghavi, K. Foreman, S. Lim et al. // Lancet. — 2012. — Vol.380.— P. 2095-2128.201.Lu C.Y. Management of the cadaveric donor of a renal transplant more thanoptimizing renal perfusion / C.Y.Lu //Kidney Int. — 1999. — Vol.56. — P.
756.202.Mange K.C. Arterial hypertension and renal allograft survival / K.C. Mange,B. Cizman, M. Joffe, H.I. Feldman // J. A. M. A. — 2000. — Vol. 283. — P. 633-638.203.Mann J.F.E. What are the short-term and long-term consequences of anemiain CRF patients?/ J.F.E. Mann // Nephrol. Dial. Transplant.— 1999. — Vol.
14. — Suppl.2. — P. 29-36.204.Manninen D.L. Work disability, functional limitations, and the health statusof kidney transplantation recipients posttransplant / D.L. Manninen, R.W. Evans, M.K.Dugan // Clin.Transpl.,1991. — Р.193-203.205.Mas V.R. Evaluation of gene panel mRNAs in urine samples of kidneytransplant recipients as a non-invasive tool of graft function / V.R.
Mas, L.A. Mas, K.J.Archer et al. // Mol. Med. — 2007. — Vol. 13, № 5-6.— P. 315-324.206.Matas A.M. 2,202 Kidney Transplant Recipients with 10 Years of GraftFunction: What Happens Next? / A.M. Matas, K.J. Gillingham, A. Humaret al. /Am. J.Transplant. — 2008. — Vol.8, №11. — P. 2410-2419.303207.Meier-Kriesche H.U. Long-term renal allograft survival: have we madesignificant progress or is it time to rethink our analytic and therapeutic strategies? / H.U.Meier-Kriesche, J.D. Schold, B. Kaplan // Am. J.
Transplant. — 2004. — Vol. 4, №8. —P. 1289-1295.208.Minshawy El. O. Albuminuria prediction of kidney function outcome inkidney transplant recipients /El.O. Minshawy, E. El-Bassuoni // Saudi J. Kidney Dis.Transpl. — 2015. — Vol.26.— P. 227-231.209.Molnar M.Z. Anemia Is Associated with Mortality in Kidney-TransplantedPatients— A Prospective Cohort Study / M.Z.
Molnar, M. Czira, C. Ambrus, L. Szeifertetal.Am. J. Transplant. — 2007. — Vol. 7, № 4. — P. 818-824.210.Moore E.M. The incidence of acute kidney injury in patients with traumaticbrain injury / E.M. Moore, R. Bellomo, A.Nichol et al. // Renal Failure. — 2010. —Vol.32, №9. — P. 1060-1065.211.Moore J. Development and evaluation of a composite risk score to predictkidney transplant failure / J. Moore, X. He, S.
Shabiret al. // Am. J. Kidney Dis. — 2011.— Vol.57, №5.— P.744-751.212.Morales J.M. Renal transplantation in patients with hepatitis C virusantibody. A long national experience. / J.M. Morales, R. Marce´n, A. Andres, B.Domı´nguez-Gil et al. // NDT Plus 3.— 2010.— P. 41— 46.213.Moreso F. Donor age and delayed graft function as predictors of renalallograft survival in rejection-free patients / F.
Moreso, D.Seron, S.Gil-Vernetet al. //Nephrol. Dial Transplant. — 1999. — Vol. 14. — P. 930-935.214.Marconi L. Donor cause of brain death in renal transplantation: a predictivefactor for graft function // L. Marconi, P. Moreira, B. Parada, et al. //TransplantationProceedings. — 2011.
— Vol.43, №1. — P. 74-76.215.Moreso F. Subclinical rejection associated with chronic allograftnephropathy in protocol biopsies as a risk factor for late graft loss / F. Moreso, M.Ibernon, M. Gomà et al. // Am. J. Transplant. — 2006. — Vol.6, №4. — P. 747-752.216.Morris R.G. Cyclosporin Therapeutic Drug Monitoring— an EstablishedService Revisited / R.G. Morris // Clin. Biochem. Rev. — 2003.
— Vol.24, №2. — P.33-46.304217.Mota A. Sirolimus-based therapy following early cyclosporine withdrawalprovides significantly improved renal histology and function at 3 years / A. Mota, M.Arias, E.I.Taskinenet al. / Am. J. Transplant. — 2004. — Vol. 4, №6. — P. 953-961.218.Nashan B. Clinical validation studies of Neoral and C2 monitoring: A review// B.
Nashan, E. Cole, G. Levy, E. Thervet // Transplantation. — 2002. — Vol.73. — Р.3-11.219.NationalKidneyFoundation/[Электронныйресурс].—Режимдоступа:https://www.kidney.org/news/newsroom/factsheets/Organ-Donation-andTransplantation-Stats220.Nauta F.L. Albuminuria, proteinuria, and novel urine biomarkers aspredictors of long-term allograft outcomes in kidney transplant recipients / F.L. Nauta,S.J. Bakker, W.
van Oeverenet al. // Am. J. Kidney Dis. — 2011. — Vol. 57, №5. — P.733-743.221.Nelson P.J. Renal ischemia-reperfusion injury Renal dendritic cells loudiysound the alarm / P.J. Nelson // Kidney Int. — 2007. — Vol. 71. — P. 604-605.222.Nevins T.E. Quantitative patterns of azathioprine adherence after renaltransplantation / T.E. Nevins, W. Thomas // Transplantation. — 2009. — Vol. 87.
— P.711-718.223.Neylan J.F. Allocation of cadaver kidneys for transplantation in the UnitedStates: consensus and controversy / J.F. Neylan, M.N. Sayegh, T.M. Coffman, G.M.Danovitch, et al. //J. Am. Soc. Nephrol. — 1999. — Vol.10. — P. 22-37.224.ReportNHS Blood and Transplant. Organ Donation and Transplantation Activity2013/14/[Электронныйресурс].—Режимдоступа:https://nhsbtmediaservices.blob.core.windows.net/organ-donationassets/pdfs/activity_report_2013_14.pdf225.Nourbala M.H. Impact of cigarette smoking on kidney transplant recipients:a systematic review / M.H. Nourbala, E. Nemati, Z. Rostami, B.
Einollahi // Iran. J.Kidney Dis.— 2011. — Vol.5, №3. — P.141-148.226.Nunes P. Cadaveric donor factor variations during a 12-year period:influence on kidney transplant outcomes / P. Nunes, B. Parada, J. Pratas, A.Roseiro et al.// Transplant.Proc. — 2006. — Vol.38, №6. — P. 1867-1869.305227.Oberai B. Myocardial and renal arteriolar thickening in cigarette smoking /B. Oberai, C.W.M.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
